Shyam S. Bansal is an assistant professor in the Department of Physiology and Cell Biology at The Ohio State University College of Medicine.
June 22, 2022
Researchers Identify, Test Novel Drug That May Stop Heart Failure Progression
June 22, 2022— Researchers at The Ohio State University Wexner Medical Center and College of Medicine have developed a…
Read More
Renibus Therapeutics (“Renibus”), a clinical-stage biotech company focusing on the prevention and treatment of cardio-renal diseases, today announced that its lead clinical candidate, RBT-1, met the primary endpoint of increasing the expression of biomarkers of cytoprotective preconditioning in a pre-specified interim Phase 2 data analysis
June 21, 2022
Renibus Therapeutics Announces Positive Interim Data from RBT-1 Phase 2 Trial
June 21, 2022 — Renibus Therapeutics (“Renibus”), a clinical-stage biotech company focusing on the prevention and…
Read More
Memorial Cardiac and Vascular Institute is First in South Florida to Use ‘Harmony’ for Valve Replacement
June 20, 2022
Memorial Cardiac and Vascular Institute is First in South Florida to Use ‘Harmony’ for Valve Replacement
June 20, 2022— Marc Chatzky may not feel like a cardiac pioneer, but he is, at least in South Florida. The Deerfield…
Read More
Dr Hilary Carswell from the University of Strathclyde
June 20, 2022
Call to Delay Clinical Trials for Gel Stroke Treatments
June 20, 2022 — Clinical trials of new gel treatments for stroke should be delayed until technology used in the tests…
Read More
A multidisciplinary team of robotics and electronic systems engineers working with cardiologists and materials scientists has developed a medical robotic apparatus that uses an external magnetic field to precisely and remotely control guidewires through tiny and tortuous blood vessels.
June 17, 2022
Robotics Engineers Pay Attention to Matters of the Heart
June 17, 2022 — A multidisciplinary team of robotics and electronic systems engineers working with cardiologists and…
Read More
Xoran Technologies has recently received a patent for a modular computed tomography (CT) system assembly. 
June 16, 2022
Xoran Announces New Patent for Modular Computed Tomography System Assembly
June 16, 2022 — Xoran Technologies has recently received a patent for a modular computed tomography (CT) system…
Read More
Cardiawave SA, a deeptech medical device manufacturer that has developed Valvosoft, a revolutionary non-invasive medical device to treat aortic stenosis, the most prevalent heart valve disease in adults, today announced positive MRI scans before and after therapeutic ultrasound treatment to assess the risk of stroke
June 15, 2022
Cardiawave Confirms the Safety of VALVOSOFT its Non-Invasive Ultrasound Treatment for Aortic Stenosis
June 15, 2022 — Cardiawave SA, a deeptech medical device manufacturer that has developed Valvosoft, a revolutionary non…
Read More
Seven finalists have been selected for the Best Abstract Award in cardiovascular computed tomography. Each finalist will present their research at the 2022 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting
June 15, 2022
Society of Cardiovascular Computed Tomography Names Finalists for Best Abstract Awards
June 15, 2022 — Seven finalists have been selected for the Best Abstract Award in cardiovascular computed tomography.…
Read More
System geometry, imaging mechanism, and performance evaluation of a self-collimating SPECT for fast dynamic cardiac imaging
June 15, 2022
Revolutionary Technology Shortens Cardiac Scan Time, Provides High-quality SPECT Images
June 15, 2022 — A cardiac SPECT imaging system performs scans 10 to 100 times faster than current SPECT systems,…
Read More
Representative case with acute anterior wall myocardial infarction: Myocardial perfusion images using 99mTc-tetrofosmin at rest (first row), 68Ga-FAPI-46 PET (second row), late gadolinium enhancement (LGE) from cardiac magnetic resonance (third row) and schematic drawings of the left ventricle (fourth row). Area of fibroblast activation exceeds infarct area and LGE signal, most common type of myocardial FAP-distribution. Bottom left: Mean areas of perfusion defect, FAPI-signal and LGE of 35 studied patients
June 15, 2022
SNMMI Image of the Year: New Biomarker Predicts Severity of Cardiac Remodeling After Heart Attack
June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI-…
Read More
Six radiology and cardiology trainees have been selected as finalists for the 16th Annual Canon Young Investigator Awards (YIA) in cardiovascular computed tomography. Each finalist will present their research at the 2022 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting
June 15, 2022
Society of Cardiovascular Computed Tomography Names Finalists for Canon Young Investigator Awards
June 15, 2022 — Six radiology and cardiology trainees have been selected as finalists for the 16th Annual Canon Young…
Read More
The global vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 million by 2030, registering a CAGR of 4.98% from 2021 to 2030.
June 14, 2022
Vascular Graft Market Size is Expected to Reach $8.13 Billion by 2030
The global vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68…
Read More
 The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI), a nonprofit organization dedicated to improving the quality of vascular care within hospitals and outpatient facilities, announces that the Centers for Medicare and Medicaid Services (CMS) has expanded coverage for Transcarotid Artery Revascularization (TCAR) to include standard surgical risk patients within the VQI TCAR Surveillance Project.
June 14, 2022
Vascular Quality Initiative Announces the Expansion of Medicare Coverage to Standard Surgical Risk Patients within their TCAR Surveillance Project
June 14, 2022 — The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI), a nonprofit organization…
Read More
A new American Heart Association scientific statement highlights the need for more data and research about sex differences in the use and response to mechanical clot removal for acute ischemic stroke and suggests a clear differentiation between sex and gender in future research
June 14, 2022
More Data Needed on Stroke Treatment and Outcomes by Gender
June 14, 2022 — A new American Heart Association scientific statement highlights the need for more data and research…
Read More
Development program for VLX-1005, a novel small molecule 12-LOX inhibitor, awarded Fast Track designation by US Food and Drug Administration
June 13, 2022
Veralox Therapeutics Announces Favorable Results of Phase 1 Studies of VLX-1005 in Development for Treatment of Heparin-Induced Thrombocytopenia
June 13, 2022 — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics…
Read More
 For below-the-knee arterial dissection repair following balloon angioplasty, innovative medical technology shows sustained treatment effect and positive impact on quality of life for patients with critical limb ischemia (CLI)
June 13, 2022
Philips Announces Positive Three-year Clinical Research Results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) Clinical Trial
June 13, 2022 — Royal Philips announced the latest results from the Tack Optimized Balloon Angioplasty (TOBA) II below-…
Read More
Individuals with diabetes display a substantially increased risk of disease in left-sided heart valves compared to controls without diabetes, a comprehensive register study at the University of Gothenburg shows.
June 10, 2022
New Light on Association Between Diabetes and Heart Valve Disease
June 10, 2022 — Individuals with diabetes display a substantially increased risk of disease in left-sided heart valves…
Read More
Pulse is a cloud platform for cardiac imaging that streamlines reporting workflows to help cardiologists be more efficient 
June 10, 2022
HeartLab Unveils Pulse 2.0, An Efficient Cardiology Imaging Platform, at ASE Scientific Sessions 2022
June 10, 2022 — HeartLab, the creator of Pulse — a cloud platform to help clinicians streamline reporting workflows —…
Read More
The ICDs market is segmented into three categories; single chamber ICDs, dual chamber ICDs, and subcutaneous ICDs, which are used to monitor heart rhythms and deliver therapy to correct heart rates that are too fast, a condition that can lead to sudden cardiac arrest.
June 10, 2022
Lower Pricing Alone Unlikely to Win Sales in the Implantable Cardioverter Defibrillators Market
June 10, 2022 — Setting a lower price to enter a competitive market with established brand leaders is a common…
Read More
product comparison charts for cardiology and health IT systems
June 09, 2022
Cardiology Product Comparison Charts Aid in Buying Decisions
Diagnostic and Interventional Cardiology (DAIC) maintains more than 50 comparison charts of product specifications from…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now